In human prostate cancer LNCaP cells, homeobox C9 (<i>HOXC9</i>) was identified as a common regulated target gene by dihydroxytestosterone and 1α,25-dihydroxyvitamin D3, but in opposite directions. This evidence concerns the gene HOXC9 and prostate carcinoma.